<http://www.plosone.org/article/fetchArticle.action?utm_medium=3Dfeed&utm_s=
ource=3Dfeedburner&utm_campaign=3DFeed%3A+plosone%2FPLoSONE+%28PLoS+ONE+Ale=
rts%3A+New+Articles%29&articleURI=3Dinfo%3Adoi%2F10.1371%2Fjournal.pone.003=
1334#pone.0031334-Wilson1>on
the effects of Ampligen (Rintatolimod) on CFS. This study constitutes
Hemispherx=92s response to the problems the FDA cited in its refusal to
approve Ampligen for CFS in Dec 2009. Hemispherx provided added proof of
Ampligens efficacy in ME/CFS and allays safety fears in its big study but
is it enough? Check out the pluses and minuses of what may be Hemispherx's
last chance for Ampligen approval for CFS in
*Ampligen Study Sparks Hope For Approval of 1st Drug for ME/CFS* at
http://phoenixrising.me/archives/8819
--=20
*
Cort Johnson
Phoenix Rising* - A non-profit 501(c)(3) charitable organization dedicated
to improving the lives of people with chronic fatigue syndrome (ME/CFS) and
other neuroendocrineimmune disorders
[image: Preview
Image]<https://www.paypal.com/cgi-bin/webscr?cmd=3D_s-xclick&hosted_button_=
id=3D5BL7MGLRCA2AC>
*
*
- *Website <http://aboutmecfs.org>*
- *Forums <http://forums.aboutmecfs.org>*
**
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
